Last update 01 Nov 2024
Luye Jiaao (Shijiazhuang) Pharmaceutical Co., Ltd.
Private Company|
2022|
Hebei Sheng, China
Last update 01 Nov 2024
Overview
Tags
Nervous System Diseases
Endocrinology and Metabolic Disease
Other Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
评价LPM526000133富马酸盐胶囊（LY03017）在健康成年受试者中单次口服给药的安全性、耐受性及药代动力学的随机、双盲、安慰剂对照、剂量递增Ⅰ期临床研究
[Translation] A randomized, double-blind, placebo-controlled, dose-escalation phase I clinical study to evaluate the safety, tolerability and pharmacokinetics of a single oral administration of LPM526000133 fumarate capsules (LY03017) in healthy adult subjects
评价LPM526000133富马酸盐胶囊（LY03017）在健康成年受试者中单次口服给药的安全性、耐受性及药代动力学的随机、双盲、安慰剂对照、剂量递增Ⅰ期临床研究
[Translation] A randomized, double-blind, placebo-controlled, dose-escalation phase I clinical study to evaluate the safety, tolerability and pharmacokinetics of a single oral administration of LPM526000133 fumarate capsules (LY03017) in healthy adult subjects
评价LPM526000133富马酸盐胶囊（LY03017）在健康成年受试者中单次口服给药的安全性、耐受性及药代动力学的随机、双盲、安慰剂对照、剂量递增Ⅰ期临床研究
[Translation] A randomized, double-blind, placebo-controlled, dose-escalation phase I clinical study to evaluate the safety, tolerability and pharmacokinetics of a single oral administration of LPM526000133 fumarate capsules (LY03017) in healthy adult subjects
100 Clinical Results associated with Luye Jiaao (Shijiazhuang) Pharmaceutical Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Luye Jiaao (Shijiazhuang) Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Luye Jiaao (Shijiazhuang) Pharmaceutical Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 25 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
1
Approved
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free